Clinical Trial

A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2025 (before its estimated June 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the Utixira Lotion + Utixira Lotion as regimen in healthy adult human subjects with dry or sensitive skin and prone to mild to moderate pruritus or urticaria
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-04.
Trial Details
NCT Number NCT06924840
Lead Sponsor SAVA Healthcare Limited
Conditions Dry Skin, Urticaria, Pruritus, Sensitive
Enrollment 32 participants
Start Date 2025-05-15
Primary Completion 2025-06-15 (estimated)
Study Completion 2025-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-18